SIRT1 and retinal disorder: In conclusion, while lack of Sirt1 promotes retinopathy in mouse OIR as we previously reported[12], the current study with Sirt1 genetic overexpression or oral treatment with gavaged Sirt1 activating compounds such as resveratrol or SRT1720 does not support their additive protective effect in retinopathy.